{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:38:41Z","timestamp":1784309921790,"version":"3.55.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1097\/md.0000000000002735","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T12:42:41Z","timestamp":1455280961000},"page":"e2735","source":"Crossref","is-referenced-by-count":15,"title":["Cytomegalovirus Infection in Ireland"],"prefix":"10.1097","volume":"95","author":[{"given":"Jaythoon","family":"Hassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"O\u2019Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Honari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cillian","family":"De Gascun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Keogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-58-20210509","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/rmv.655","article-title":"Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection","volume":"20","author":"Cannon","year":"2010","journal-title":"Rev Med Virol"},{"key":"R2-58-20210509","first-page":"210","article-title":"Low cytomegalovirus sero-prevalence in Irish pregnant women","volume":"98","author":"Knowles","year":"2005","journal-title":"Irish Med J"},{"key":"R3-58-20210509","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1128\/CMR.00034-08","article-title":"Immunobiology of cytomegalovirus: from bench to bedside","volume":"22","author":"Crough","year":"2009","journal-title":"Clin Micro Rev"},{"key":"R4-58-20210509","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cis818","article-title":"State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician","volume":"55","author":"Egli","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R5-58-20210509","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/j.1600-6143.2008.02191.x","article-title":"Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation","volume":"8","author":"Mattes","year":"2008","journal-title":"Am J Transplant"},{"key":"R6-58-20210509","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R7-58-20210509","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/ajt.13012","article-title":"Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates","volume":"15","author":"Cantis\u00e1n","year":"2015","journal-title":"Am J Transplant"},{"key":"R8-58-20210509","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the National Health and Nutrition Examination Surveys, 1988\u20132004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R9-58-20210509","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/CVI.00203-06","article-title":"National serosurvey of cytomegalovirus in Australia","volume":"13","author":"Seale","year":"2006","journal-title":"Clin Vaccine Immunol"},{"key":"R10-58-20210509","first-page":"16","article-title":"Seroprevalence to cytomegalovirus in the Portuguese population, 2002\u20132003","volume":"23","author":"Lopo","year":"2011","journal-title":"Euro Surveill"},{"key":"R11-58-20210509","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1744-313X.2008.00779.x","article-title":"HLA-A, B, Cw, DRB1, DQB1 and DPB1 alleles and haplotypes in the genetically homogenous Irish population","volume":"35","author":"Dunne","year":"2008","journal-title":"Int J Immunogenet"},{"key":"R12-58-20210509","first-page":"171","article-title":"HLA antigen frequency of Northern Ireland blood donors","volume":"47","author":"Middleton","year":"1978","journal-title":"Ulster Med J"},{"key":"R13-58-20210509","first-page":"48","article-title":"HL\u2014A typing in Northern Ireland 1971\u20131974","volume":"44","author":"Nelson","year":"1975","journal-title":"Ulster Med J"},{"key":"R14-58-20210509","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jcv.2013.12.007","article-title":"Incidence of congenital cytomegalovirus infection in Ireland: implications for screening and diagnosis","volume":"59","author":"Waters","year":"2014","journal-title":"J Clin Virol"},{"key":"R15-58-20210509","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/rmv.544","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Rev Med Virol"},{"key":"R16-58-20210509","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s11845-009-0327-3","article-title":"Late-onset CMV disease following CMV prophylaxis","volume":"178","author":"Donnelly","year":"2009","journal-title":"Ir J Med Sci"},{"key":"R17-58-20210509","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(97)05535-9","article-title":"Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients","volume":"350","author":"Gane","year":"1997","journal-title":"Lancet"},{"key":"R18-58-20210509","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Valganciclovir Solid Organ Transplant Study Group. Efficacy and safety of valganciclovir versus oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000002735","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:00:38Z","timestamp":1620961238000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201602090-00058"}},"subtitle":["Seroprevalence, HLA Class I Alleles, and Implications"],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":18,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000002735","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}